Realm Reaches End of The Road And Seeks Buyer

 
• By Kevin Grogan

The US company listed in the UK has been devastated by the failure of its investigational eczema drug in Phase II trials in August and has hired an advisor to look for strategic alternatives, including a sale.

Dead end
Failures in the clinic spell the end for Realm Therapeutics • Source: Shutterstock

More from Dermatological

More from Therapy Areas